• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大豆苷元通过下调 TPI1 干扰糖酵解/糖异生途径抑制肝癌细胞的存活。

Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1.

机构信息

Hubei Engineering Technology Research Center of Chinese Materia Medica Processing, College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.

出版信息

Biofactors. 2022 Jul;48(4):883-896. doi: 10.1002/biof.1826. Epub 2022 Feb 3.

DOI:10.1002/biof.1826
PMID:35118741
Abstract

Daidzin (DDZ) is a natural brassin-like compound extracted from the soybean, and has been found to have therapeutic potential against tumors in recent years. This study investigates the therapeutic effect of DDZ on hepatocellular carcinoma cells and elucidates the possible mechanisms of action. The viability of HCCLM3 and Hep3B cells was detected by MTT assay. Western blots and qPCR were used to detect the protein and mRNA levels of proliferation and apoptosis related genes. Gas chromatography-mass spectrometry (GC-MS) was used for metabolome analysis. In vivo antitumor effects were assessed in nude mice engrafted with HCC cell lines. Our results show that DDZ treatment dose-dependently inhibited cell viability, migration, and survival. The expressions of CDK1, BCL2, MYC, and survivin were reduced, while the expressions of BAX and PARP were increased in DDZ treated cells. The differentially expressed metabolites detected in DDZ treated cultures are associated with glycolysis/gluconeogenesis pathways. Bioinformatic analysis identified TPI1, a gene in the glycolysis pathway with prognostic value for hepatocellular carcinoma (HCC), and DDZ treatment downregulated this gene. In vivo experiments show that DDZ significantly reduced the tumor volume and weight, and inhibited Ki67 expression within tumors. This study shows that DDZ interfered with the survival and migration of hepatocellular carcinoma cells, likely via TPI1 and the gluconeogenesis pathway.

摘要

大豆中提取的天然拟南芥素化合物大豆苷元(DDZ)近年来被发现具有抗肿瘤的治疗潜力。本研究探讨了 DDZ 对肝癌细胞的治疗作用,并阐明了其可能的作用机制。MTT 法检测 HCCLM3 和 Hep3B 细胞的活力。Western blot 和 qPCR 检测增殖和凋亡相关基因的蛋白和 mRNA 水平。气相色谱-质谱联用(GC-MS)进行代谢组学分析。裸鼠荷瘤实验评估体内抗肿瘤作用。结果表明,DDZ 处理剂量依赖性地抑制细胞活力、迁移和存活。DDZ 处理细胞中 CDK1、BCL2、MYC 和 survivin 的表达降低,BAX 和 PARP 的表达增加。DDZ 处理培养物中检测到的差异表达代谢物与糖酵解/糖异生途径有关。生物信息学分析鉴定了糖酵解途径中与肝癌(HCC)预后相关的 TPI1 基因,DDZ 处理下调了该基因。体内实验表明,DDZ 显著降低了肿瘤体积和重量,并抑制了肿瘤内 Ki67 的表达。本研究表明,DDZ 干扰了肝癌细胞的存活和迁移,可能通过 TPI1 和糖异生途径。

相似文献

1
Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1.大豆苷元通过下调 TPI1 干扰糖酵解/糖异生途径抑制肝癌细胞的存活。
Biofactors. 2022 Jul;48(4):883-896. doi: 10.1002/biof.1826. Epub 2022 Feb 3.
2
Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.PCK1基因过表达通过激活糖异生和抑制糖酵解途径拮抗肝细胞癌。
Cell Physiol Biochem. 2018;47(1):344-355. doi: 10.1159/000489811. Epub 2018 May 11.
3
Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.MEK 抑制通过独立的 MYC 和 BIM 调控抑制肝细胞癌生长。
Cell Oncol (Dordr). 2019 Jun;42(3):369-380. doi: 10.1007/s13402-019-00432-4. Epub 2019 Feb 20.
4
Diosmetin inhibits cell growth and proliferation by regulating the cell cycle and lipid metabolism pathway in hepatocellular carcinoma.地奥司明通过调控肝癌细胞周期和脂代谢通路抑制细胞生长增殖。
Food Funct. 2021 Nov 29;12(23):12036-12046. doi: 10.1039/d1fo02111g.
5
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.IGF2 通过表观遗传机制在肝细胞癌中上调,并且是实验模型中可操作的癌基因产物。
Gastroenterology. 2016 Dec;151(6):1192-1205. doi: 10.1053/j.gastro.2016.09.001. Epub 2016 Sep 7.
6
Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis .胡椒乙胺通过调节氨基酸代谢抑制肝癌细胞生长和增殖,并抑制肿瘤发生。
Int J Biol Sci. 2021 Oct 22;17(15):4340-4352. doi: 10.7150/ijbs.64675. eCollection 2021.
7
Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.肿瘤坏死因子α诱导蛋白 1 通过选择性地下调 CSNK2B 作为一种新型肿瘤抑制因子,阻断肝癌中核因子-κB 的激活。
EBioMedicine. 2020 Jan;51:102603. doi: 10.1016/j.ebiom.2019.102603. Epub 2020 Jan 3.
8
Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.lncRNA SBF2-AS1 的下调通过调节 miR-361-5p/TGF-β1 信号通路抑制肝癌细胞的增殖和迁移。
Aging (Albany NY). 2021 Aug 2;13(15):19260-19271. doi: 10.18632/aging.203248.
9
Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.硫酸异麦芽低聚糖抑制裸鼠肝癌生长和转移。
BMC Cancer. 2011 Apr 22;11:150. doi: 10.1186/1471-2407-11-150.
10
Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.大豆苷元通过抑制肿瘤细胞中锰超氧化物歧化酶的表达和 PI3K/Akt/mTOR 的激活来靶向上皮间质转化过程。
Life Sci. 2022 Apr 15;295:120395. doi: 10.1016/j.lfs.2022.120395. Epub 2022 Feb 16.

引用本文的文献

1
Research progress on the anti-cancer mechanisms of edible salty-flavored Chinese materia medica.食用咸味中药抗癌机制的研究进展
Front Pharmacol. 2025 Jun 20;16:1598978. doi: 10.3389/fphar.2025.1598978. eCollection 2025.
2
Anticancer potential of daidzin: a comprehensive literature review.大豆苷元的抗癌潜力:一项全面的文献综述。
Med Oncol. 2025 Jun 26;42(8):285. doi: 10.1007/s12032-025-02839-6.
3
Daidzin improves the cisplatin chemosensitivity for osteosarcoma via binding to β-catenin protein and suppressing the wnt pathway.
大豆苷元通过与β-连环蛋白结合并抑制Wnt信号通路,提高骨肉瘤对顺铂的化疗敏感性。
Sci Rep. 2025 Feb 14;15(1):5484. doi: 10.1038/s41598-025-89766-8.
4
An Insight into Research Advances on Herbal and Phytochemical Approaches to the Management of Hepatocellular Carcinoma from January 2020 to July 2024.2020年1月至2024年7月期间草药及植物化学物质治疗肝细胞癌的研究进展洞察
Anticancer Agents Med Chem. 2025;25(15):1049-1076. doi: 10.2174/0118715206348951241120120918.
5
The novel HSP90 monoclonal antibody 9B8 ameliorates articular cartilage degeneration by inhibiting glycolysis via the HIF-1 signaling pathway.新型热休克蛋白90单克隆抗体9B8通过缺氧诱导因子-1信号通路抑制糖酵解来改善关节软骨退变。
Heliyon. 2024 Aug 8;10(16):e35603. doi: 10.1016/j.heliyon.2024.e35603. eCollection 2024 Aug 30.
6
Lactylome Analysis Unveils Lactylation-Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem Cells.乳酰组分析揭示了肝癌干细胞干性重塑的乳酰化依赖机制。
Adv Sci (Weinh). 2024 Oct;11(38):e2405975. doi: 10.1002/advs.202405975. Epub 2024 Aug 5.
7
Therapeutic Effects of Natural Products on Liver Cancer and Their Potential Mechanisms.天然产物对肝癌的治疗作用及其潜在机制。
Nutrients. 2024 May 27;16(11):1642. doi: 10.3390/nu16111642.
8
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1 Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment.单细胞RNA测序显示,TPI1恶性肝细胞的富集与肝癌转移和免疫抑制微环境有关。
J Hepatocell Carcinoma. 2024 Feb 22;11:373-383. doi: 10.2147/JHC.S453249. eCollection 2024.
9
Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.磷酸丙糖异构酶 1 可能是喉鳞状细胞癌的风险预测因子:一项整合了 bulk RNA、单细胞 RNA 和蛋白免疫组化的多中心研究。
Eur J Med Res. 2023 Dec 15;28(1):591. doi: 10.1186/s40001-023-01568-8.
10
The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy.肠道微生物群和与微生物代谢相关的益生菌在癌症预防和治疗中的作用。
Front Pharmacol. 2022 Nov 14;13:1025860. doi: 10.3389/fphar.2022.1025860. eCollection 2022.